In this episode of our hematology podcast, we delve into the world of relapsed and refractory multiple myeloma with Dr. Samir A. Al-Hadidi from the University of Arkansas.
Join us as we discuss the evolving treatment options for patients who experience relapse or disease progression after initial therapy. Dr. Al-Hadidi provides valuable insights into monitoring patients, discussing escalating treatments, and the role of novel therapies such as CAR-T and bispecific antibodies.
From monitoring strategies to managing side effects, this episode of oncology podcast covers essential information for community oncologists caring for patients with relapsed or refractory multiple myeloma.
Don't miss out on this informative discussion on the current treatment landscape for multiple myeloma. Stay informed and stay connected with the latest advancements in hematology.
Oncology Brothers: Practice-Changing Cancer Discussions